Anzeige
Mehr »
Login
Donnerstag, 15.04.2021 Börsentäglich über 12.000 News von 660 internationalen Medien
Relay Medical: Das sind gewaltige Neuigkeiten! Die Lizenz zum Millionen scheffeln?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von Pharmaceutical Business Review

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
MiTrodelvy granted accelerated approval by USFDA for metastatic urothelial cancer
MiDr. Reddy's secures EUA for Sputnik V in India
DiAirway Therapeutics' IND application for AT-100 gets FDA acceptance to treat Covid-19
MoSanofi acquires Tidal Therapeutics
FrBiogen and Bio-Thera Solutions announce commercialisation and license agreement for BAT1806
08.04.AbbVie presents applications to FDA and EMA for approval of SKYRIZI in psoriatic arthritis
07.04.USFDA extends review period for Eli Lilly and Incyte's sNDA for baricitinib
07.04.AB Science and University of Chicago to conduct Covid-19 treatment research
06.04.Antengene announces China's NMPA approval for IND application for ATG-019 clinical trial
06.04.Anixa and OntoChem enter next stage of Covid-19 anti-viral therapy development
05.04.AbbVie announces extension of USFDA review period for Rinvoq sNDA
01.04.Piramal to acquire APIs manufacturer Hemmo Pharmaceuticals
01.04.Takeda Pharmaceutical concludes sale of OTC and non-core assets to Orifarm for $670m
31.03.Amgen agrees to acquire biopharmaceutical company Rodeo Therapeutics
30.03.USFDA sends CRL to Merck's sBLA regarding KEYTRUDA
29.03.USFDA approves Abecma to treat relapsed or refractory multiple myeloma
26.03.Japan approves Bristol Myers Squibb's B-cell lymphoma therapy
26.03.EMA validates Gilead Sciences' application for breast cancer therapy
26.03.US NIH-led study identifies SARS-CoV-2 virus infects cells in mouth
25.03.UCLA-led lab study identifies potential drug to treat SARS-CoV-2 virus
24.03.Fidia Farmaceutici acquires Sanofi's anti-inflammatory drugs portfolio
23.03.FDA approves Zealand Pharma's Zegalogue for hypoglycemia treatment
23.03.Dyadic and Medytox to co-develop Covid-19 variant fighting vaccines
22.03.USFDA approves Janssen's PONVORY for treatment of multiple sclerosis
19.03.Anima signs new strategic collaboration deal with Takeda